Author name: DrugPatentWatch – Make Better Decisions

PONVORY (ponesimod) Vanda pharms inc Patent: 9,000,018 Expiration: Nov 16, 2024 See More … For more information on how DrugPatentWatch […]

PONVORY (ponesimod) Vanda pharms inc Patent: 9,000,018 Expiration: Nov 16, 2024 See More … For more information on how DrugPatentWatch […]

DEFENCATH (heparin sodium; taurolidine) Cormedix Patent: 9,339,036 Expiration: Nov 2, 2024 See More … For more information on how DrugPatentWatch […]

BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 9,238,076 Expiration: Oct 15, 2024 See More … For more information on how DrugPatentWatch […]

NUCYNTA ER (tapentadol hydrochloride) Collegium pharm inc Patent: 8,114,383 Expiration: Oct 10, 2024 See More … For more information on […]

NUCYNTA ER (tapentadol hydrochloride) Collegium pharm inc Patent: 8,114,383 Expiration: Oct 10, 2024 See More … For more information on […]

NOCTIVA (desmopressin acetate) Acerus pharms Patent: 7,799,761 Expiration: Sep 26, 2024 See More … For more information on how DrugPatentWatch […]

AMITIZA (lubiprostone) Sucampo pharma llc Patent: 7,795,312 Expiration: Sep 17, 2024 See More … For more information on how DrugPatentWatch […]

ORILISSA (elagolix sodium) Abbvie Patent: 7,056,927 Expiration: Sep 10, 2024 See More … For more information on how DrugPatentWatch can […]

EPIDUO (adapalene; benzoyl peroxide) Galderma labs lp Patent: 7,964,202 Expiration: Sep 1, 2024 See More … For more information on […]